Shulman DeMeo Asset Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
Shulman DeMeo Asset Management's AMGN Position: Q2 2026 in Review
Shulman DeMeo Asset Management reduced its Amgen (AMGN) stake by 0.65% in Q2 2026, selling an estimated $2.05K and leaving 914 shares worth $331K. The position accounts for 0.06% of the portfolio, ranked #104.
Shulman DeMeo Asset Management first reported a position in AMGN in Q1 2021 and has held it in 21 quarters since. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Shulman DeMeo Asset Management held 914 shares of Amgen worth $331K as of Q2 2026.
- Shulman DeMeo Asset Management sold 6 Amgen shares in Q2 2026, an estimated $2.05K.
- Amgen made up 0.06% of Shulman DeMeo Asset Management's portfolio in Q2 2026, its #104 holding.
- Shulman DeMeo Asset Management first reported a position in Amgen in Q1 2021 and has held it in 21 quarters since.
- 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Shulman DeMeo Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.